Massimiliano Bonifacio
Publications by Year
Research Areas
Chronic Myeloid Leukemia Treatments, Chronic Lymphocytic Leukemia Research, Myeloproliferative Neoplasms: Diagnosis and Treatment, Acute Lymphoblastic Leukemia research, Eosinophilic Disorders and Syndromes
Most-Cited Works
- → Blinatumomab for minimal residual disease in adults with B-cell precursor acute lymphoblastic leukemia(2018)818 cited
- → Dasatinib–Blinatumomab for Ph-Positive Acute Lymphoblastic Leukemia in Adults(2020)479 cited
- → Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study(2023)169 cited
- → Life after ruxolitinib: Reasons for discontinuation, impact of disease phase, and outcomes in 218 patients with myelofibrosis(2019)145 cited
- → Drug resistance and BCR‐ABL kinase domain mutations in Philadelphia chromosome–positive acute lymphoblastic leukemia from the imatinib to the second‐generation tyrosine kinase inhibitor era: The main changes are in the type of mutations, but not in the frequency of mutation involvement(2013)139 cited
- → International prognostic scoring system for mastocytosis (IPSM): a retrospective cohort study(2019)136 cited
- → Efficacy of tyrosine kinase inhibitors in Ph-like acute lymphoblastic leukemia harboring ABL-class rearrangements(2019)132 cited
- → Ropeginterferon alfa-2b versus phlebotomy in low-risk patients with polycythaemia vera (Low-PV study): a multicentre, randomised phase 2 trial(2021)127 cited
- → Long-Term Results of the Dasatinib-Blinatumomab Protocol for Adult Philadelphia-Positive ALL(2023)126 cited
- → Clonal mast cell disorders in patients with severe Hymenoptera venom allergy and normal serum tryptase levels(2015)121 cited